Kura Oncology to Present Preclinical Data on Pipeline

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Kura Oncology to Present Preclinical Data on Pipeline Programs at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

LA JOLLA, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical stage biopharmaceutical company developing precision medicines for cancer, today announced it will be presenting two posters at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2016), taking place November 29 – December 2, 2016 in Munich.  The presentations will feature preclinical data from Kura Oncology’s KO‒947 ERK inhibitor and menin-MLL inhibitor programs.  Abstracts are currently available online at the European Cancer Organisation website ( www.ecco-org.eu/Events/ENA2016 ).

Posters Date & Time: Nov. 30, 2016, 10:15 a.m. - 5:00 p.m. (CET) Poster Title: Discovery of novel menin-MLL small molecule inhibitors that display high potency and selectivity in vitro and in vivo Session: Epigenetic modulators Abstract Number: 264 Poster Location: P090, ICM – Internationales Congress Center München

Date & Time: Dec. 1, 2016, 10:15 a.m. - 5:00 p.m. (CET) Poster Title: KO-947, a potent and selective ERK inhibitor with slow dissociation kinetics Session: Molecular targeted agents II Abstract Number: 381 Poster Location: P060, ICM – Internationales Congress Center München

About Kura Oncology

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company’s pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s lead drug candidate is tipifarnib, a farnesyl transferase inhibitor, which is currently being studied in multiple Phase 2 clinical trials. The preclinical pipeline includes KO-947, an ERK inhibitor, and a menin-MLL program. For additional information about Kura Oncology, please visit the company’s website at www.kuraoncology.com .

CONTACT INFORMATION INVESTOR CONTACT: Robert H. Uhl Managing Director Westwicke Partners, LLC (858) 356-5932 robert.uhl@westwicke.com MEDIA CONTACT: Mark Corbae Vice President Canale Communications (619) 849-5375 mark@canalecomm.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 12

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 11

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 13

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 13

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 11

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 10

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 9

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading

Top 5 Most Recently Viewed Articles

Eesti Energia Announces New Management Board for 2026

Updated Category News Views 345

Steering Eesti Energia into the Future Eesti Energia has officially confirmed the members of its Management Board, gearing up for a transition starting January 1, 2026. With a fresh focus on integrated renewable energy solutions, the new board combines seasoned leadership with a drive towards innovation. A Strong Leadership Team The newly structured Management Board will...

Continue Reading
Havila Kystruten AS Enhances LNG Supply Model for Cost Efficiency

Updated Category News Views 144

Havila Kystruten AS Enhances LNG Procurement Strategy Havila Kystruten AS is making significant strides in optimizing its LNG procurement process. The company has successfully renegotiated its LNG procurement agreement, allowing them to acquire approximately one-third of their LNG volume through a new supplier located in Northern Norway, which will be in effect until...

Continue Reading
Jack Dorsey Promotes Bitcoin Payments for Square Users

Updated Category News Views 211

Jack Dorsey's Bitcoin Payment Initiative Jack Dorsey, co-founder and CEO of Block Inc., has reached out to merchants using the Square platform, inviting them to explore the exciting new feature of Bitcoin payments. The push towards integrating Bitcoin within Square's existing payment system reflects a growing trend of digital currencies being embraced in everyday...

Continue Reading
Skyline Builders Group Holding Secures $17.775 Million in Funding

Updated Category News Views 177

Skyline Builders Group Holding Limited Announces Funding Development Skyline Builders Group Holding Limited (NASDAQ: SKBL) is making headlines with its announcement of a significant financial maneuver aimed at bolstering its operations and future growth. The company has secured a private placement amounting to approximately $17.775 million, which will be pivotal in...

Continue Reading
Bloomberg Unveils Updated Commodity Index Weightings for 2026

Updated Category News Views 1794

Bloomberg Reveals 2026 Commodity Index Composition Bloomberg has recently announced its target weights and composition for the Bloomberg Commodity Index (BCOM) for the year 2026. Launched in 1998, BCOM serves as a significant benchmark for the commodities market, boasting an estimated total assets under management (AUM) of $108.8 billion. As of January 2026, the BCOM will...

Continue Reading